Is bladder biopsy necessary at three or six months post BCG therapy?

Author： Highshaw R.A. Tanaka S.T. Evans C.P. deVere White R.W.

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.21, Iss.3, 2003-05, pp. : 207-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Three versus six months of exercise training in breast cancer survivors

By Sprod Lisa

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 413-419

Springer Publishing Company

Access to resources Recommend Favorite

Failure of Intravesical Interferon-Alfa-2b for the Treatment of Patients with Superficial Bladder Cancer Previously Failing Intravesical BCG Therapy

By Hudson M.A. Ratliff T.L.

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 3, 1995-05 ,pp. : 115-118

Elsevier

Access to resources Recommend Favorite

Trans-urethral whole layer core biopsy for detection of residual tumor after neoadjuvant therapy in invasive bladder cancer

By Hoshi S. Ono K. Suzuki K.-i. Ohyama C. Namima T. Orikasa S.

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 3, 2001-05 ,pp. : 85-89

Elsevier

Access to resources Recommend Favorite

Is Sentinel Node Biopsy Necessary in Conservatively Treated DCIS?

By Julian Thomas Land Stephanie Fourchotte Virginie Haile Sarah Fisher Edwin Mamounas Eleftherios Costantino Joseph Wolmark Norman

Annals of Surgical Oncology, Vol. 14, Iss. 8, 2007-08 ,pp. : 2202-2208

Springer Publishing Company

Access to resources Recommend Favorite

Neopterin as a monitoring parameter for treatment with BCG in superficial bladder cancer

By Mack D. Gomahr A. Herold M. Frick J.

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 1025-1026

Elsevier

Access to resources Recommend Favorite